Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Latest news  -  Page 723
Latest

Industry titans debate future of digital music

By   /  Wednesday, September 16th, 2015  /  Latest news, South Coast, Technology, Top Stories  /  Comments Off on Industry titans debate future of digital music

Three titans of the music industry had mixed views of the future of digital music and artists’ ability to profit from it during a panel discussion in Santa Barbara Wednesday evening. The MIT Enterprise Forum of the Central Coast featured Tom Conrad, co-founder and retired chief technology officer of Pandora; Marc Geiger, head of the Read More →

Read More →
Latest

Amgen buys biotech company, partners with another

By   /  Wednesday, September 16th, 2015  /  Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen buys biotech company, partners with another

Thousand Oaks-based biopharmaceutical giant Amgen bought a Netherlands-based company and partnered with a Monrovia-based company in an effort to fend off competitors. Amgen announced Sept. 16 that it will buy Dezima, a biotech company focused on developing new treatments for dyslipidemia, a disease where a person has an abnormal amount of lipids in their blood. Read More →

Read More →
Latest

Goleta-based Sientra to offer 525,000 new shares

By   /  Tuesday, September 15th, 2015  /  Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Goleta-based Sientra to offer 525,000 new shares

Goleta-based breast implant manufacturer Sientra updated documents for its second  public offering on Sept. 14 and it will offer 525,000 new shares. On Sept. 3, Sientra filed documents with the Securities and Exchange Commission for a new public offering. At the time, the documents did not list the amount of shares Sientra planned to offer. Read More →

Read More →
Latest

Hewlett-Packard laying off 25,000 to 30,000 employees

By   /  Tuesday, September 15th, 2015  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Hewlett-Packard laying off 25,000 to 30,000 employees

Hewlett-Packard is laying off 25,000 to 30,000 employees globally as part of a restructuring program that will save the company $2.7 billion per year. HP announced the layoffs on Sept. 15 at a meeting of its securities analysts. The cuts represent about 10 percent of HP’s workforce of about 302,000. It wasn’t immediately clear how Read More →

Read More →
Latest

Carey & Hanna moving from Ventura to Oxnard

By   /  Tuesday, September 15th, 2015  /  Latest news, Personal Finance  /  Comments Off on Carey & Hanna moving from Ventura to Oxnard

Ventura-based Carey & Hanna Tax and Wealth Planners is relocating to a larger office in Oxnard. Carey & Hanna Tax and Wealth Planners will move into the former National University building at 1000 Town Center Drive, Suite 200, on Oct. 22. The office has been located at 1445 Donlon Road, Suite 6 in Ventura since Read More →

Read More →
Latest

Oil workers file lawsuit against Plains All American Pipeline

By   /  Monday, September 14th, 2015  /  Energy, Latest news, Law  /  Comments Off on Oil workers file lawsuit against Plains All American Pipeline

A lawsuit representing oil industry workers who were laid off following the Refugio oil spill was filed against Plains All American Pipeline, Santa Barbara-based law firm Cappello & Noel recently announced. Richard Lilygren, who has worked on the offshore oil platforms near Santa Barbara for more than a decade, filed the lawsuit in U.S. District Court on Read More →

Read More →
Latest

Amgen licenses cancer drug to NatPharma

By   /  Monday, September 14th, 2015  /  Latest news, Tri-County Public Companies  /  Comments Off on Amgen licenses cancer drug to NatPharma

Amgen has licensed an experimental cancer drug to a Chicago biotech company founded and controlled by billionaire Patrick Soon-Shiong. NatPharma LLC is licensing the rights to AMG 337 from Thousand Oaks-based Amgen to develop and sell AMG 337. The drug is an experimental, phase-two cancer treatment. The licensing agreement is the second between Amgen and Read More →

Read More →